Johnson & Johnson/Ethicon Inc. has announced new plans to collaborate with researchers and smaller device firms to improve treatments for solid tumors, persistent atrial fibrillation and joint replacement, among other conditions.
J&J Announces New Device Collaborations
The Johnson & Johnson Innovation Center projects include a focus on solid-tumor resections, knee replacement procedures and atrial fibrillation ablation – as well as tracking down biomarkers tied to diabetes and prostate cancer.